Shaolin Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Shaolin Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-77,164	Closed	-$29K	–	469
2023 Q3	$29K	Buy	+77,164	New	+$16.6K	﹤0.01%	365
2023 Q2	–	Sell	-77,164	Closed	-$5.24K	–	692
2023 Q1	$5K	Hold	77,164	–	–	﹤0.01%	669
2022 Q4	$6K	Hold	77,164	–	–	﹤0.01%	706
2022 Q3	$5K	Hold	77,164	–	–	﹤0.01%	894
2022 Q2	$6K	Hold	77,164	–	–	﹤0.01%	938
2022 Q1	$20K	Hold	77,164	–	–	﹤0.01%	884
2021 Q4	$40K	Hold	77,164	–	–	﹤0.01%	715
2021 Q3	$63K	Sell	77,164 -3,000	-4%	-$2.78K	﹤0.01%	535
2021 Q2	$82K	Sell	80,164 -4,724	-6%	-$4.66K	﹤0.01%	502
2021 Q1	$93K	Buy	+84,888	New	+$153K	﹤0.01%	482

Other funds holding TLSIW

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return

MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return

Shaolin Capital Management's TLSIW Position: Q4 2023 in Review

Shaolin Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2023, closing a stake of 77,164 shares — an estimated $29K sold.

Shaolin Capital Management first reported a position in TLSIW in Q1 2021 and held it in 10 quarters. The position peaked at $93K in Q1 2021. 22 funds tracked by Wall St. Rank hold TLSIW as of Q4 2023.

Shaolin Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q4 2023 after selling out during the quarter.
Shaolin Capital Management sold 77,164 TriSalus Life Sciences Warrant shares in Q4 2023, an estimated $29K.
Shaolin Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 10 quarters.
Shaolin Capital Management's TriSalus Life Sciences Warrant position peaked at $93K in Q1 2021.
22 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2023.

Based on Shaolin Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.